MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jso.27482

Медицинская библиотека · Journal of surgical oncology · 2023

Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.

Lopez Joseph, Subramanian Tejas, Durell Jonathan, Levyn Helena, Wong Richard, Shah Jatin, LaQuaglia Michael P, Gerstle Justin Ted

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Neuroblastomas rarely occur as primary tumors in the cervical region. Therefore, very little has been reported regarding treatment strategies, complications, and outcomes of these cervical neuroblastomas. The goal of this study is to review the presentation, management, and outcomes of all primary cervical pediatric neuroblastoma cases at a single tertiary care center.

METHODS

A retrospective cohort review of all neuroblastoma patients treated at a single center were performed. All patients with primary cervical neuroblastoma were reviewed for demographic information, tumor characteristics, treatment, and outcomes.

RESULTS

Thirty (1.8%) patients were found to have undergone treatment for cervical neuroblastoma tumors diagnosed on average at 2.1 years old. Most presented with a swollen neck/palpable mass ± Horner's syndrome. Based on features including tumor staging, N-myc proto-oncogene protein (MYCN) amplification status, histology, most were deemed intermediate or high risk. Treatment strategies centered around chemotherapeutic regimens with surgery when possible as well as various adjuvant treatments including radiation therapy, immunotherapy, bone marrow transplant, and a neuroblastoma vaccine. Ten (33.3%) of patients experienced treatment-related complications and four (13.3%) died as a result of their disease progression. All four patients were high-risk patients, two of which had MYCN amplification.

CONCLUSION

Cervical neuroblastomas generally have favorable outcomes. These tumors can be treated effectively with chemotherapy and surgical intervention with various adjuvant therapies. MYCN amplification and higher stage disease presentation contribute to worse outcomes.

Для цитирования: Lopez Joseph, Subramanian Tejas, Durell Jonathan, Levyn Helena, Wong Richard, Shah Jatin, LaQuaglia Michael P, Gerstle Justin Ted. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.. Journal of surgical oncology. 2023. DOI: 10.1002/jso.27482.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.